Does Routine Submucosal Injection Improve Complete Resection of 4-20 mm Neoplastic Colorectal Polyps?
1 other identifier
interventional
429
1 country
1
Brief Summary
This is a prospective, multi-endoscopist, single center, clinical study at tertiary referral center that addresses an important current challenge in the prevention of colorectal cancer (CRC), namely, how to improve the complete removal of CRC precursors. This study will observe the potential benefit of specific polypectomy technique in conjunction with a systematic submucosal injection prior to the polyp resection. This study will evaluate the completeness and incompleteness of the resection of colorectal neoplastic polyps during the procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable colorectal-cancer
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 8, 2020
CompletedFirst Posted
Study publicly available on registry
September 16, 2020
CompletedStudy Start
First participant enrolled
January 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedDecember 8, 2022
December 1, 2022
9 months
September 8, 2020
December 6, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incomplete resection rate (IRR)
The number of incomplete polyps resected after polypectomy, as defined by any neoplastic tissue found in marginal biopsies.
Day 1
Secondary Outcomes (5)
Immediate bleeding complications
Day 1
Delayed bleeding complications
14 days after the initial procedure
Other severe complications
14 days after the initial procedure
Proportion of polyps considered interpretable for complete polyp removal
14 days after the initial procedure
Incomplete resection of colorectal polyps
14 days after the initial procedure
Study Arms (1)
Cold snare polypectomy with a submucosal injection
EXPERIMENTALThe procedure will include a cold snare polypectomy with a submucosal injection done prior to the resection.
Interventions
The cold snare polypectomy in conjunction with a submucosal injection is a procedure during which the endoscopist resects the colorectal polyps during a colonoscopy, without any electrocautery.
Eligibility Criteria
You may qualify if:
- Signed consent form; aged 45-80 years old, indication to undergo a colonoscopy
You may not qualify if:
- Known inflammatory bowel disease; active colitis; coagulopathy; familial polyposis syndrome; poor general health, defined as an American Society of Anesthesiologists (ASA) physical status class \>3; emergency colonoscopies, hospitalized patients or patients referred from the emergency room.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Universitaire de Montréal
Montreal, Quebec, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daniel von Renteln, MD
Centre hospitalier de l'Université de Montréal (CHUM)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2020
First Posted
September 16, 2020
Study Start
January 12, 2021
Primary Completion
October 1, 2021
Study Completion
July 1, 2022
Last Updated
December 8, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share